Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Dermatology and TherapyOpen Access

Skin-Directed Therapies in Mycosis Fungoides: An Update

View Full Paper
Ask AI
Bookmark
Share

Authors

MTMaciej TotaMŁMagdalena ŁykoPMPiotr Misiąg

Discussion

Loading...

Member takes

Overview

This review highlights the efficacy of skin-directed therapies in managing mycosis fungoides, indicating promising treatment options.

Key Points

  • Skin-directed therapies effectively manage mycosis fungoides, enhancing patient quality of life.
  • Treatment includes topical agents like corticosteroids and psoralen-UVA, demonstrating various efficacy levels.
  • We present mechanisms, efficacy data, and adverse effects for established and emerging therapies.
  • Ongoing clinical trials aim to evaluate new skin-directed therapies for mycosis fungoides, suggesting future advancements.

Cite This Study

Tota et al. (2025) studied this question.

synapsesocial.com/papers/68c1c23554b1d3bfb60efaachttps://doi.org/10.1007/s13555-025-01511-1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cutaneous T‐cell lymphomas—An update 20212021 · 87 citations
  2. 2Complete resolution of mycosis fungoides tumors with imiquimod 5% cream: a case series2017 · 27 citations
  3. 3Photodynamic therapy with methylaminolevulinate as a valuable treatment option for unilesional cutaneous T‐cell lymphoma2006 · 81 citations
  4. 4Photodynamic Therapy as an Effective Treatment for Cutaneous Lymphomas2022 · 7 citations
  5. 5Biological Effects of Bexarotene in Cutaneous T-Cell Lymphoma2005 · 76 citations